What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Quantum mechanics
Richard M. Martin spends much of his time researching Internal medicine, Prostate cancer, Oncology, Odds ratio and Meta-analysis.
His work carried out in the field of Internal medicine brings together such families of science as Endocrinology and Breast feeding.
The various areas that Richard M. Martin examines in his Prostate cancer study include Prostate, Randomized controlled trial and Confidence interval.
His Oncology study combines topics in areas such as Relative risk, Vitamin D and neurology and Pancreatic cancer.
The study incorporates disciplines such as Single-nucleotide polymorphism and Type 2 diabetes in addition to Odds ratio.
The Meta-analysis study combines topics in areas such as Preferred walking speed, Prospective cohort study, Epidemiology and Grip strength.
His most cited work include:
- Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. (1748 citations)
- 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer (1230 citations)
- Effect of Infant Feeding on the Risk of Obesity Across the Life Course: A Quantitative Review of Published Evidence (940 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Prostate cancer, Oncology, Cancer and Mendelian randomization.
His research ties Endocrinology and Internal medicine together.
His Prostate cancer research is multidisciplinary, relying on both Body mass index, Prostate, Randomized controlled trial and Gynecology.
His Body mass index research is multidisciplinary, incorporating perspectives in Anthropometry, Cohort study, Pediatrics and Cohort.
Richard M. Martin combines subjects such as Case-control study, Meta-analysis, Hazard ratio, Vitamin D and neurology and Risk factor with his study of Oncology.
His biological study deals with issues like Demography, which deal with fields such as Obesity and Breastfeeding.
He most often published in these fields:
- Internal medicine (58.30%)
- Prostate cancer (38.02%)
- Oncology (37.26%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (58.30%)
- Oncology (37.26%)
- Mendelian randomization (22.81%)
In recent papers he was focusing on the following fields of study:
Richard M. Martin mainly focuses on Internal medicine, Oncology, Mendelian randomization, Prostate cancer and Cancer.
His research related to Odds ratio, Breast cancer, Confidence interval, Hazard ratio and Epidemiology might be considered part of Internal medicine.
His work deals with themes such as Body mass index, Ovarian cancer, Proportional hazards model, Vitamin D and neurology and Risk factor, which intersect with Oncology.
His Body mass index research also works with subjects such as
- Demography and related Obesity,
- Cohort that connect with fields like Waist and Cohort study.
His Prostate cancer research includes themes of Stage, Prostate and Randomized controlled trial.
His Cancer study incorporates themes from Multivariate analysis and MEDLINE.
Between 2017 and 2021, his most popular works were:
- The MR-Base platform supports systematic causal inference across the human phenome (899 citations)
- Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (268 citations)
- Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality: The CAP Randomized Clinical Trial (148 citations)
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
